Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
13.08
+0.23 (1.79%)
At close: Dec 20, 2024, 4:00 PM
12.52
-0.56 (-4.29%)
After-hours: Dec 20, 2024, 6:38 PM EST
Syndax Pharmaceuticals Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for SNDX stock have an average target of 37.64, with a low estimate of 23 and a high estimate of 51. The average target predicts an increase of 187.77% from the current stock price of 13.08.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SNDX stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 8 | 8 |
| Buy | 2 | 3 | 3 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 11 | 11 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $51 | Strong Buy | Reiterates | $51 | +289.91% | Dec 10, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $33 → $38 | Buy | Maintains | $33 → $38 | +190.52% | Nov 21, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $37 → $45 | Strong Buy | Maintains | $37 → $45 | +244.04% | Nov 19, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $49 → $51 | Strong Buy | Maintains | $49 → $51 | +289.91% | Nov 18, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $47 → $49 | Strong Buy | Maintains | $47 → $49 | +274.62% | Nov 12, 2024 |
Financial Forecast
Revenue This Year
125.56M
Revenue Next Year
98.94M
from 125.56M
Decreased by -21.20%
EPS This Year
-2.89
from -2.98
EPS Next Year
-3.78
from -2.89
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 474.6M | 256.4M | 329.3M | |||
| Avg | 125.6M | 98.9M | 226.8M | |||
| Low | 15.7M | 45.7M | 140.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | 104.2% | 232.8% | |||
| Avg | - | -21.2% | 129.3% | |||
| Low | - | -63.6% | 42.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 1.34 | -1.77 | -2.13 | |||
| Avg | -2.89 | -3.78 | -2.85 | |||
| Low | -3.82 | -4.70 | -3.43 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.